Literature DB >> 8200167

Thrombocytosis. Etiologic analysis of 663 patients.

M D Yohannan1, K E Higgy, S A al-Mashhadani, C R Santhosh-Kumar.   

Abstract

Six hundred sixty-three children aged 1 to 16 years with thrombocytosis (defined as a platelet count of more than 500 x 10(9)/L) seen in a university hospital over a 1-year period were studied prospectively for etiology. The causes of thrombocytosis were infection (30.6%), hemolytic anemia (19.3%), tissue damage (15.2%), rebound thrombocytosis (14.8%), chronic inflammation (4.1%), renal disorders (4.1%), and malignancy (2%). Thrombocytosis associated with multiple, simultaneous causative factors was seen in 3.3% of cases. Among all patients with infections, osteomyelitis and septic arthritis were associated with higher platelet counts than other infections (P < .0001). Thrombocytosis secondary to infections was significantly more common in children under 5 years of age, whereas chronic inflammation, malignancy, and renal disorders were more common causes of thrombocytosis in children over 5 years of age. Thrombocytosis of 1 million or more platelets was seen in 13 (2%) children. No thrombocytosis-related complications were seen in any children, and none required any specific treatment. Thrombocytosis is a frequent finding in children. It is due to a variety of etiologic factors and is of little clinical discriminatory value. It is often due to an acute-phase phenomenon in response to infection, tissue damage, blood loss, or anemia, and is rarely due to malignancy.

Entities:  

Mesh:

Year:  1994        PMID: 8200167     DOI: 10.1177/000992289403300605

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  13 in total

1.  Clinicohematological study of thrombocytosis.

Authors:  Dinesh Yadav; Jagdish Chandra; Sunita Sharma; Varinder Singh
Journal:  Indian J Pediatr       Date:  2010-06-08       Impact factor: 1.967

2.  BTS guidelines for the management of pleural infection in children.

Authors:  I M Balfour-Lynn; E Abrahamson; G Cohen; J Hartley; S King; D Parikh; D Spencer; A H Thomson; D Urquhart
Journal:  Thorax       Date:  2005-02       Impact factor: 9.139

3.  Two cases of pediatric essential thrombocythemia managed effectively with hydroxyurea.

Authors:  Vikas Dua; Satya Prakash Yadav; Vijay Kumar; Renu Saxena; Anupam Sachdeva
Journal:  Int J Hematol       Date:  2012-10-07       Impact factor: 2.490

4.  The role of thrombocytapheresis in the management of extreme thrombocytosis: a 6 years' experience from a tertiary care center.

Authors:  Deepika Chenna; Isha Polavarapu; Dhivya Kandasamy; Ganesh Mohan; Shamee Shastry
Journal:  Med Pharm Rep       Date:  2021-10-30

5.  High rate of extreme thrombocytosis indicates bone marrow hyperactivity and splenic dysfunction among congenital diaphragmatic hernia patients.

Authors:  Hannah Gu; Matthew Devine; Holly L Hedrick; Natalie E Rintoul; Christopher S Thom
Journal:  Platelets       Date:  2021-10-26       Impact factor: 4.236

6.  Extreme thrombocytosis in admissions to paediatric intensive care: no requirement for treatment.

Authors:  Alison Denton; Peter Davis
Journal:  Arch Dis Child       Date:  2007-06       Impact factor: 3.791

7.  Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies.

Authors:  Jonathan S Bleeker; William J Hogan
Journal:  Thrombosis       Date:  2011-06-08

8.  Successful use of the cell separator hemonetics multicomponent collection system+ for therapeutic thrombocytapheresis in a low body weight child of essential thrombocythemia.

Authors:  Abhay Singh; Soniya Nityanand; Atul Sonker; Sanjeev Kumar
Journal:  Asian J Transfus Sci       Date:  2015 Jul-Dec

9.  Clinicohematological study of thrombocytosis in children.

Authors:  Nathiya Subramaniam; Suneel Mundkur; Pushpa Kini; Nalini Bhaskaranand; Shrikiran Aroor
Journal:  ISRN Hematol       Date:  2014-01-29

10.  Postoperative thrombocytosis: An unusual case report.

Authors:  Garima Baweja Madaan; Zeeba S Jairajpuri; Farooq F Hajini; Sujata Jetley
Journal:  Int J Appl Basic Med Res       Date:  2015 Sep-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.